EPISODE · Jun 21, 2024 · 1 MIN
Restylane SHAYPE: Galderma's Game-Changer for Chin Augmentation
from AI Automation Minute · host Dr. Teri Fisher
This episode covers the recent approval of Restylane® SHAYPE™ by Health Canada, a new hyaluronic acid injectable designed specifically for chin augmentation. Listeners will learn about the innovative NASHA HD™ technology that makes this the firmest HA injectable on the market, providing a non-surgical option that mimics the qualities of an implant. The episode delves into the compelling results from a 12-month study conducted across Canada, highlighting high satisfaction rates among participants. It also discusses the broader implications for aesthetic medicine and what this means for future non-surgical treatments. Stay connected with Dr. Teri Fisher and explore the latest in AI and automation for healthcare: 🎥 Watch on YouTube for in-depth AI tutorials: YouTube.com/@DrTeriFisher📲 Follow on Instagram for automation tips: @DrTeriFisher💡 Discover AI tools for your practice: DrTeriFisher.com🎙 Listen to the long-form podcast: Anti-Aging Insights 👉 Subscribe to AI Automation Minute for your daily dose of AI-powered efficiency, and share with colleagues who want to work smarter, not harder! #AIAutomationMinute #DrTeriFisher #HealthcareAI
Embed this episode
What this episode covers
This episode covers the recent approval of Restylane® SHAYPE™ by Health Canada, a new hyaluronic acid injectable designed specifically for chin augmentation. Listeners will learn about the innovative NASHA HD™ technology that makes this the firmest HA injectable on the market, providing a non-surgical option that mimics the qualities of an implant. The episode delves into the compelling results from a 12-month study conducted across Canada, highlighting high satisfaction rates among participa...
NOW PLAYING
Restylane SHAYPE: Galderma's Game-Changer for Chin Augmentation
No transcript for this episode yet
Similar Episodes
No similar episodes found.